AJP - Renal Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 275: F255-F261, 1998;
0363-6127/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pillay, S. N.
Right arrow Articles by Coe, F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pillay, S. N.
Right arrow Articles by Coe, F. L.
Vol. 275, Issue 2, F255-F261, August 1998

Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization

Sokalingum N. Pillay, John R. Asplin, and Fredric L. Coe

Department of Medicine, Section of Nephrology, University of Chicago, Chicago, Illinois 60637

Urine produced by normal human kidneys is almost always supersaturated with respect to calcium oxalate (CaOx), the most common constituent of human kidney stones. Crystallization, with risk of renal damage and kidney stones, appears to be affected by molecules in urine that retard nucleation, growth, aggregation, and renal cell adherence of CaOx. The repertoire of such molecules is incompletely known. We have purified a 28-kDa protein from urine using salt precipitation, preparative isoelectric focusing, and sizing chromatography. Amino acid composition and NH2-terminal amino sequence analysis showed complete homology to calgranulin. Calgranulin was found to be a potent inhibitor of CaOx crystal growth (44% of control) and aggregation (50% of control) in the nanomolar range. Calgranulin cDNA was cloned from a human kidney expression library. Western analysis of human and rat kidney homogenates and mRNA temporal expression from two independent renal epithelial cell lines showed that calgranulin is produced in the kidney. Given its urinary abundance and potency, calgranulin may contribute importantly to the normal urinary inhibition of crystal growth and aggregation and therefore to the renal defense against clinical stone disease.

nephrolithiasis; crystal growth; crystal aggregation; S100 protein


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
J. J. De Yoreo, S. R. Qiu, and J. R. Hoyer
Molecular modulation of calcium oxalate crystallization.
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1123 - F1132.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
K. J. Bergsland, J. K. Kelly, B. J. Coe, and F. L. Coe
Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers
Am J Physiol Renal Physiol, September 1, 2006; 291(3): F530 - F536.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
R. Schindler, C. Radke, K. Paul, and U. Frei
Renal problems after lung transplantation of cystic fibrosis patients
Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1324 - 1328.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online